PAVmed Inc. (PAVM) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you. Thank you. Thank you. Thank you. Thank you. Good morning and welcome to the PavMed's fourth quarter 2025 Business Update conference call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question and answer session. If at any time during this call you require immediate assistance, please press star zero for the operator. This call is being recorded on Monday, March 30th, 2026. I would now like to turn the conference over to Matt Riley, PavMed's Vice President of Investor Relations. Please go ahead. Thank you, Operator. Good morning, everyone. Thank you for participating in today's business update call. Joining me today on the call are Dr. Alishan Akhlog, Chairman and CEO of PABMED, along with Dennis McGrath, Chief Financial Officer. The press release announcing our business update and financial results is available on PABMED's website. Please take a moment to read the disclaimers about forward-looking statements in the press release. The business update, press release, and the conference call all include forward-looking statements And these forwarding statements are subject to known and unknown risks or uncertainties that may cause actual results to differ materially from statements made. Factors that could cause actual results to differ are described in the disclaimer and in our filings with the SEC. For a list and a description of these and other important risks and uncertainties that may affect future operations, see Part 1, Item 1A, entitled Risk Factors and PATH Measurements Recent Annual Report on Forms 10-K filed with SEC and and any subsequent updates five and quarter reports on Forms 10-Q and subsequent Forms 8-K. Except as required by law, PABMED disclaims any intentions or obligations to publicly upd...